Pre-earnings options volume in Eledon Pharmaceuticals (ELDN) is normal with puts leading calls 4:3. Implied volatility suggests the market is anticipating a move near 8.0%, or 17c, after results are released. Median move over the past eight quarters is 2.1%.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELDN:
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
- Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
- Eledon Pharmaceuticals Reports Promising Phase 2 Trial Results
- Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart